What are the indications for using steroids (e.g., dexamethasone) as adjunctive therapy in meningitis?

Indications for Steroids in Meningitis

Dexamethasone should be administered empirically to all adults (10 mg IV every 6 hours for 4 days) and children (0.15 mg/kg IV every 6 hours for 4 days) with suspected acute bacterial meningitis in high-income countries, given before or with the first dose of antibiotics. 1

Primary Indications

Adults and Children (Beyond Neonatal Age)

• All suspected bacterial meningitis cases in high-income countries warrant empiric dexamethasone 1
• The strongest benefit occurs in:
  • Pneumococcal meningitis: Reduces mortality (RR 0.84) and unfavorable outcomes from 52% to 26% 1, 2
  • H. influenzae meningitis: Significantly reduces severe hearing loss (RR 0.34) 3

Timing is Critical

• Start dexamethasone 15-20 minutes before or with the first antibiotic dose 1, 2
• If antibiotics already given, dexamethasone can still be initiated up to 4 hours after the first antibiotic dose (expert consensus) 1
• Starting later than this window loses the benefit of preventing antibiotic-induced bacterial lysis and inflammatory cascade 4, 1

When to Stop Dexamethasone

Discontinue dexamethasone if:

• Patient does not have bacterial meningitis 1
• Pathogen identified is NOT S. pneumoniae or H. influenzae 1

Specific Pathogen Considerations

• Listeria monocytogenes: Stop dexamethasone immediately—associated with increased mortality in observational data 4
• N. meningitidis: No demonstrated benefit or harm; stopping is reasonable but can be individualized 4, 1

Contraindications and Special Populations

Do NOT Use Dexamethasone In:

• Neonates (<1 month old): Current evidence insufficient; not recommended 1
  • Exception: One small RCT showed benefit but had methodological flaws 5
• Low-income countries: No beneficial effect demonstrated; multiple studies show lack of efficacy 1, 3

Outcomes Improved by Dexamethasone

Based on high-quality evidence in high-income countries:

• Hearing loss: Reduces severe hearing loss (RR 0.67) and any hearing loss (RR 0.74) 3
• Neurological sequelae: Reduces short-term complications (RR 0.83) 3
• Mortality in pneumococcal meningitis: Reduces death (RR 0.48 overall; RR 0.84 in pneumococcal cases) 2, 3

Dosing Regimen

Standard Protocol 1

• Adults: 10 mg IV every 6 hours × 4 days
• Children: 0.15 mg/kg IV every 6 hours × 4 days
• Route: Intravenous preferred; can use intramuscular if IV access unavailable

Common Pitfalls to Avoid

1. Delaying dexamethasone: Must give before or with antibiotics—not hours later
2. Continuing in Listeria meningitis: Actively harmful; stop immediately when identified 4
3. Using in neonates: Evidence does not support this practice 1
4. Applying high-income country data to low-income settings: No benefit demonstrated in resource-limited settings 3
5. Withholding antibiotics to give dexamethasone first: Give both together; never delay antibiotics

Safety Profile

Dexamethasone is generally well-tolerated in this setting:

• No increased gastrointestinal bleeding in the landmark trial 2
• Recurrent fever more common (RR 1.27) but not clinically significant 3
• Short 4-day course minimizes typical steroid complications

Geographic Considerations

The benefit of dexamethasone is restricted to high-income countries with high standards of medical care 1, 3. This likely relates to:

• Earlier presentation and diagnosis
• Better supportive care
• Different causative organism patterns
• Antibiotic resistance patterns